In addition, we found metapristone was capable of greatly reducing expressions of CXCR4 to interrupt the SDF-1/CXCR4 chemokine axis and the related downstream signaling pathways, resulting in inhibition of cell proliferation, migration, invasion and functional adhesion of ovarian cancer [17]. This evidence concerns the gene CXCR4 and ovarian carcinoma.